Cargando…
ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma
Currently, only a few available targeted drugs are considered to be effective in stomach adenocarcinoma (STAD) treatment. The PARP inhibitor olaparib is a molecularly targeted drug that continues to be investigated in BRCA-mutated tumors. However, in tumors without BRCA gene mutations, particularly...
Autores principales: | Gu, Zhuoyu, Wang, Liping, Yao, Xiaohan, Long, Qian, Lee, Kaping, Li, Jieyao, Yue, Dongli, Yang, Shuangning, Liu, Yanfen, Li, Na, Li, Yixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583252/ https://www.ncbi.nlm.nih.gov/pubmed/33093458 http://dx.doi.org/10.1038/s41419-020-03107-3 |
Ejemplares similares
-
Cysteine Accessibility in ClC-0 Supports Conservation of the ClC Intracellular Vestibule
por: Engh, Anita M., et al.
Publicado: (2005) -
Chloride Channelopathies of ClC-2
por: Bi, Miao Miao, et al.
Publicado: (2013) -
ClC chloride channels
por: Mindell, Joe, et al.
Publicado: (2001) -
Involvement of the Tubular ClC-Type Exchanger ClC-5 in Glomeruli of Human Proteinuric Nephropathies
por: Ceol, Monica, et al.
Publicado: (2012) -
Research and progress on ClC-2
por: Wang, Hongwei, et al.
Publicado: (2017)